Skip to content

The Association Between Urinary Incontinence, Physical Performance, Physical Activity Levels in Women With Low Back Pain

The Association Between Urinary Incontinence, Physical Performance and Physical Activity Level in Women With Low Back Pain a Cross-Sectional Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05339516
Enrollment
146
Registered
2022-04-21
Start date
2021-11-29
Completion date
2022-05-31
Last updated
2022-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Physical Inactivity, Urinary Incontinence

Brief summary

The study is searching for the correlation between low back pain(LBP), physical performance, urinary incontinence and physical activity levels in women. Lower physical performance, more frequent urinary incontinence and less physical activity are expected in women who have LBP.

Interventions

None listed

Sponsors

Pinar Yasar
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

For Healthy Group: * 30-65 years women * Agreeing to involve in the study Inclusion Criteria For Women With Low Back Pain Group: * 30-65 years women * Having low back pain for at least 3 months * Scoring pain at least 1 in Visual Analog Scale(VAS) * Agreeing to involve in the study

Exclusion criteria

* Any kind of surgery history in low back area * Surgery history in lower limbs * Acute low back pain * Having a neurological disease * Having sensory deficists * The ones with rheumatological diseases which can cause low back pain * Being pregnant * Having a disc hernia pressuring to sacral nerves

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale(VAS)BaselineVisual Analogue Scale (VAS) will be used to evaluate the severity of low back pain. The back pain they feel during activity and rest will be questioned separately from the participants. For this assessment, patients will be asked to mark their pain intensity on a 10-centimeter line. Pain intensity will be determined by measuring the distance of the marked point to the 0 point with a tape measure. Scoring is made between 0-10 and 0 means no pain- 10 means the most severe pain imaginable.
International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)BaselineThe six-question form allows evaluation of the frequency of urinary incontinence and during which activities it occurs. The validity and reliability study of the Turkish version of the test was done by Çetinel et al. made by Scoring is done with frequency, amount and degree of impact questions, a total score between 0-21 is obtained. A low score indicates that urinary incontinence affects the quality of life less, and a high score indicates that the involvement is high. For the ICIQ-SF, a score of 8 and above was determined as the most appropriate cut-off value for irritating urine leakage.
International Physical Activity Questionnaire(IPAQ)BaselineThe physical activity level of the participants will be evaluated with the International Physical Activity Questionnaire (IPAQ). The survey consists of a total of 5 sections and 27 questions. Information is obtained about the light, moderate and vigorous activities that the person has done in the last week and the sitting time. For physical activities performed for at least 10 minutes, the MET value (metabolic equivalent) is multiplied by the number of days and minutes to obtain the MET-min/week score. Classification according to the energy level spent in METs is made as no physical activity (MET=\<600), insufficient activity (MET=600-3000), and adequate activity level (MET= \>3000).
Muscle Strength TestingBaselineThe muscle strength of the participants will be determined by the Manual Muscle Test. The person is asked to move against gravity by taking the appropriate position for the muscle to be evaluated. If the movement can be done up to the desired part (3) it is scored as medium, if it receives minimal resistance (3+) if it gets a little good from the middle, if it can get moderate resistance (4) good, if it can get full resistance (5) it is normal. Muscle strength of the shoulder and elbow flexors in the upper extremity and hip flexors in the lower extremities will be evaluated.
Endurance TestingBaselineTrunk Flexor Endurance test and Wall-Sit-Hold Test will be used to evaluate trunk and lower extremity endurance. Wall-Sit- Hold Test: The participant leans his back against the wall, spreads his feet shoulder-width apart and squats by bringing his knees to 90 degrees of flexion. The time during which the position can be held is recorded
Agility TestingBaselineBurpee Agility Test will be used for the agility evaluation of the participants. The test consists of 4 stages. Initially, the standing participant moves into a half-squat position, then into a stance on the floor with hands and feet close together. Then the participant takes the plank position with the arms fully extended by throwing his legs back and then returning to the previous position. He then stands up and returns to the starting position and claps his hands above his head once. The standard test duration is 3 minutes, but a modified version of 1 minute will be used in order to be applicable to individuals with low physical activity.
Flexibility TestingBaselineFlexibility will be assessed with the sit and reach test. The person sits in a long sitting position with his legs straight, the soles of the feet are in contact with the 31 cm high evaluation table. The participant is then asked to reach forward as far as he can, keeping his knees straight, with one hand on the other. Starting position and the farthest point that the middle finger can reach at the end of the movement is measured and the difference is recorded.

Countries

Turkey (Türkiye)

Contacts

Primary ContactPinar Yasar, MSc
pinarergoz@gmail.com+905350145340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026